New metabolic vulnerability in small cell lung cancer (SCLC) that can be targeted by existing drug called like mizoribine has been identified by a research team at the UT Southwestern Medical Center.
from Medindia Health News https://ift.tt/2lSA1Mg
No comments:
Post a Comment